» Articles » PMID: 16490727

Guidelines for the Use of Antidepressants in Painful Rheumatic Conditions

Overview
Journal Eur J Pain
Publisher Wiley
Date 2006 Feb 24
PMID 16490727
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: Antidepressants are widely used to treat painful chronic rheumatic conditions but, contrary to neuropathic conditions, little is known about their true analgesic properties and value in these situations. Our group, which focuses on pain in rheumatology, aimed to develop recommendations for the use of antidepressants in rheumatology, based on evidence-based review of published data and expert opinion.

Method: We identified relevant drugs and conditions and searched Medline, Embase and Pascal (1966-2003) for relevant publications in a number of European languages. We scored each study for quality, and used an expert consensus approach to formulate recommendations.

Results: We identified 77 studies and 12 meta-analyses and literature review on the use of antidepressant to treat painful rheumatological conditions. Forty-nine of these clinical studies were considered valid and were used to develop the recommendations. When evidence was lacking we based recommendations on our clinical experience.

Conclusions: These recommendations for the treatment of painful rheumatological conditions with antidepressants were developed using evidence-based and expert consensus approaches and are the first of their kind in this field. Our review of the literature highlights the need for further, well-designed clinical studies of the use of antidepressants to treat painful rheumatological conditions.

Citing Articles

The association of depression and anxiety with treatment outcomes in patients with rheumatoid arthritis - a pooled analysis of five randomised controlled trials.

Manning-Bennett A, Hopkins A, Sorich M, Proudman S, Foster D, Abuhelwa A Ther Adv Musculoskelet Dis. 2022; 14:1759720X221111613.

PMID: 35898566 PMC: 9310212. DOI: 10.1177/1759720X221111613.


Antidepressant Fluoxetine Does Not Appear to Interfere With Key Translational Parameters in the Rat Adjuvant-induced Arthritis Model.

Seveljevic-Jaran D, Kalliokoski O, Abelson K, Hau J In Vivo. 2022; 36(2):635-642.

PMID: 35241516 PMC: 8931903. DOI: 10.21873/invivo.12747.


A methodological quality assessment of systematic reviews and meta-analyses of antidepressants effect on low back pain using updated AMSTAR.

Panahi M, Mohseni M, Yarandi R, Ramezani Tehrani F BMC Med Res Methodol. 2020; 20(1):14.

PMID: 31973739 PMC: 6979288. DOI: 10.1186/s12874-020-0903-9.


Monoamines as Drug Targets in Chronic Pain: Focusing on Neuropathic Pain.

Bravo L, Llorca-Torralba M, Berrocoso E, Mico J Front Neurosci. 2020; 13:1268.

PMID: 31942167 PMC: 6951279. DOI: 10.3389/fnins.2019.01268.


Disruption of 5-HT2A receptor-PDZ protein interactions alleviates mechanical hypersensitivity in carrageenan-induced inflammation in rats.

Wattiez A, Pichon X, Dupuis A, Hernandez A, Privat A, Aissouni Y PLoS One. 2013; 8(9):e74661.

PMID: 24058620 PMC: 3776748. DOI: 10.1371/journal.pone.0074661.